Literature DB >> 16024808

Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation.

Veerendra Munugalavadla1, Louis C Dore, Bai Lin Tan, Li Hong, Melanie Vishnu, Mitchell J Weiss, Reuben Kapur.   

Abstract

Stem cell factor (SCF), erythropoietin (Epo), and GATA-1 play an essential role(s) in erythroid development. We examined how these proteins interact functionally in G1E cells, a GATA-1(-) erythroblast line that proliferates in an SCF-dependent fashion and, upon restoration of GATA-1 function, undergoes GATA-1 proliferation arrest and Epo-dependent terminal maturation. We show that SCF-induced cell cycle progression is mediated via activation of the Src kinase/c-Myc pathway. Restoration of GATA-1 activity induced G1 cell cycle arrest coincident with repression of c-Kit and its downstream effectors Vav1, Rac1, and Akt. Sustained expression of each of these individual signaling components inhibited GATA-1-induced cell cycle arrest to various degrees but had no effects on the expression of GATA-1-regulated erythroid maturation markers. Chromatin immunoprecipitation analysis revealed that GATA-1 occupies a defined Kit gene regulatory element in vivo, suggesting a direct mechanism for gene repression. Hence, in addition to its well-established function as an activator of erythroid genes, GATA-1 also participates in a distinct genetic program that inhibits cell proliferation by repressing the expression of multiple components of the c-Kit signaling axis. Our findings reveal a novel aspect of molecular cross talk between essential transcriptional and cytokine signaling components of hematopoietic development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024808      PMCID: PMC1190349          DOI: 10.1128/MCB.25.15.6747-6759.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  88 in total

1.  Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells.

Authors:  F C Yang; R Kapur; A J King; W Tao; C Kim; J Borneo; R Breese; M Marshall; M C Dinauer; D A Williams
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

2.  C-kit mutations in core binding factor leukemias.

Authors:  A Beghini; P Peterlongo; C B Ripamonti; L Larizza; R Cairoli; E Morra; C Mecucci
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

3.  Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.

Authors:  K E Nichols; J D Crispino; M Poncz; J G White; S H Orkin; J M Maris; M J Weiss
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

4.  KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.

Authors:  M L Lux; B P Rubin; T L Biase; C J Chen; T Maclure; G Demetri; S Xiao; S Singer; C D Fletcher; J A Fletcher
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 5.  Early signaling pathways activated by c-Kit in hematopoietic cells.

Authors:  D Linnekin
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

6.  c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia.

Authors:  M Gari; A Goodeve; G Wilson; P Winship; S Langabeer; D Linch; E Vandenberghe; I Peake; J Reilly
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

7.  Rac2, a hematopoiesis-specific Rho GTPase, specifically regulates mast cell protease gene expression in bone marrow-derived mast cells.

Authors:  Yi Gu; Michael C Byrne; Nivanka C Paranavitana; Bruce Aronow; Jamie E Siefring; Maria D'Souza; Heidi F Horton; Lawrence A Quilliam; David A Williams
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

Review 8.  c-Kit and c-kit mutations in mastocytosis and other hematological diseases.

Authors:  M Boissan; F Feger; J J Guillosson; M Arock
Journal:  J Leukoc Biol       Date:  2000-02       Impact factor: 4.962

9.  Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.

Authors:  S Uddin; S Kottegoda; D Stigger; L C Platanias; A Wickrema
Journal:  Biochem Biophys Res Commun       Date:  2000-08-18       Impact factor: 3.575

10.  Distinguishing regulatory DNA from neutral sites.

Authors:  Laura Elnitski; Ross C Hardison; Jia Li; Shan Yang; Diana Kolbe; Pallavi Eswara; Michael J O'Connor; Scott Schwartz; Webb Miller; Francesca Chiaromonte
Journal:  Genome Res       Date:  2003-01       Impact factor: 9.043

View more
  61 in total

Review 1.  From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.

Authors:  Shilpa M Hattangadi; Piu Wong; Lingbo Zhang; Johan Flygare; Harvey F Lodish
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

2.  MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.

Authors:  Nadia Felli; Laura Fontana; Elvira Pelosi; Rosanna Botta; Desirée Bonci; Francesco Facchiano; Francesca Liuzzi; Valentina Lulli; Ornella Morsilli; Simona Santoro; Mauro Valtieri; George Adrian Calin; Chang-Gong Liu; Antonio Sorrentino; Carlo M Croce; Cesare Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

3.  Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus.

Authors:  Huie Jing; Christopher R Vakoc; Lei Ying; Sean Mandat; Hongxin Wang; Xingwu Zheng; Gerd A Blobel
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

4.  Green fluorescent protein transgene driven by Kit regulatory sequences is expressed in hematopoietic stem cells.

Authors:  Francesco Cerisoli; Letizia Cassinelli; Giuseppe Lamorte; Stefania Citterio; Francesca Bertolotti; Maria Cristina Magli; Sergio Ottolenghi
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

5.  Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation.

Authors:  Isla Hamlett; Julia Draper; John Strouboulis; Francisco Iborra; Catherine Porcher; Paresh Vyas
Journal:  Blood       Date:  2008-07-14       Impact factor: 22.113

6.  SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.

Authors:  Tamara Tripic; Wulan Deng; Yong Cheng; Ying Zhang; Christopher R Vakoc; Gregory D Gregory; Ross C Hardison; Gerd A Blobel
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

7.  Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis.

Authors:  Ming Yu; Laura Riva; Huafeng Xie; Yocheved Schindler; Tyler B Moran; Yong Cheng; Duonan Yu; Ross Hardison; Mitchell J Weiss; Stuart H Orkin; Bradley E Bernstein; Ernest Fraenkel; Alan B Cantor
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

Review 8.  Transcription factor networks in erythroid cell and megakaryocyte development.

Authors:  Louis C Doré; John D Crispino
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

9.  Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1.

Authors:  Stephan Kadauke; Maheshi I Udugama; Jan M Pawlicki; Jordan C Achtman; Deepti P Jain; Yong Cheng; Ross C Hardison; Gerd A Blobel
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

Review 10.  Transcription factor mutations as a cause of familial myeloid neoplasms.

Authors:  Jane E Churpek; Emery H Bresnick
Journal:  J Clin Invest       Date:  2019-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.